Plasmacytoid dendritic cells orchestrate innate and adaptive anti-tumor immunity induced by oncolytic coxsackievirus A21
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Plasmacytoid dendritic cells orchestrate innate and adaptive anti-tumor immunity induced by oncolytic coxsackievirus A21 ; volume:7 ; number:1 ; day:1 ; month:7 ; year:2019 ; pages:1-16 ; date:12.2019
Journal for ImmunoTherapy of Cancer ; 7, Heft 1 (1.7.2019), 1-16, 12.2019
- Urheber
-
Müller, Louise M. E.
Holmes, Matthew
Michael, Joanne L.
Scott, Gina B.
West, Emma J.
Scott, Karen J.
Parrish, Christopher
Hall, Kathryn
Stäble, Sina
Jennings, Victoria A.
Cullen, Matthew
McConnell, Stewart
Langton, Catherine
Tidswell, Emma L.
Shafren, Darren
Samson, Adel
Harrington, Kevin J.
Pandha, Hardev
Ralph, Christy
Kelly, Richard J.
Cook, Gordon
Melcher, Alan A.
Errington-Mais, Fiona
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40425-019-0632-y
- URN
-
urn:nbn:de:101:1-2019103022550407772185
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Müller, Louise M. E.
- Holmes, Matthew
- Michael, Joanne L.
- Scott, Gina B.
- West, Emma J.
- Scott, Karen J.
- Parrish, Christopher
- Hall, Kathryn
- Stäble, Sina
- Jennings, Victoria A.
- Cullen, Matthew
- McConnell, Stewart
- Langton, Catherine
- Tidswell, Emma L.
- Shafren, Darren
- Samson, Adel
- Harrington, Kevin J.
- Pandha, Hardev
- Ralph, Christy
- Kelly, Richard J.
- Cook, Gordon
- Melcher, Alan A.
- Errington-Mais, Fiona
- SpringerLink (Online service)
Ähnliche Objekte (12)
Coxsackievirus B3—Its Potential as an Oncolytic Virus
Development of recombinant oncolytic Coxsackievirus B3 for treatment of colorectal carcinoma
![Versuche zur Pathogenitätsabschwächung von Coxsackievirus der Typen A7 [A] und A21 [A] durch Transfektion](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Versuche zur Pathogenitätsabschwächung von Coxsackievirus der Typen A7 [A] und A21 [A] durch Transfektion
Oncolytic activity of a coxsackievirus B3 strain in human endometrial cancer cell lines
Application Route and Immune Status of the Host Determine Safety and Oncolytic Activity of Oncolytic Coxsackievirus B3 Variant PD-H
Prospect of Plasmacytoid Dendritic Cells in Enhancing Anti-Tumor Immunity of Oncolytic Herpes Viruses
Genetic diversity of Coxsackievirus A21 associated with sporadic cases of acute respiratory infections in Malaysia
Phase 1b study of intravenous coxsackievirus A21 (V937) and ipilimumab for patients with metastatic uveal melanoma
A.21.
Momente, [...]. A2.1
Liesegang A21
Miteinander!, [...]. A2.1
Coxsackievirus B3—Its Potential as an Oncolytic Virus
Development of recombinant oncolytic Coxsackievirus B3 for treatment of colorectal carcinoma
Versuche zur Pathogenitätsabschwächung von Coxsackievirus der Typen A7 [A] und A21 [A] durch Transfektion
Oncolytic activity of a coxsackievirus B3 strain in human endometrial cancer cell lines
Application Route and Immune Status of the Host Determine Safety and Oncolytic Activity of Oncolytic Coxsackievirus B3 Variant PD-H
Prospect of Plasmacytoid Dendritic Cells in Enhancing Anti-Tumor Immunity of Oncolytic Herpes Viruses
Genetic diversity of Coxsackievirus A21 associated with sporadic cases of acute respiratory infections in Malaysia
Phase 1b study of intravenous coxsackievirus A21 (V937) and ipilimumab for patients with metastatic uveal melanoma
A.21.
Momente, [...]. A2.1
Liesegang A21
Miteinander!, [...]. A2.1
Coxsackievirus B3—Its Potential as an Oncolytic Virus
Development of recombinant oncolytic Coxsackievirus B3 for treatment of colorectal carcinoma
Versuche zur Pathogenitätsabschwächung von Coxsackievirus der Typen A7 [A] und A21 [A] durch Transfektion
Oncolytic activity of a coxsackievirus B3 strain in human endometrial cancer cell lines
Application Route and Immune Status of the Host Determine Safety and Oncolytic Activity of Oncolytic Coxsackievirus B3 Variant PD-H
Prospect of Plasmacytoid Dendritic Cells in Enhancing Anti-Tumor Immunity of Oncolytic Herpes Viruses
Genetic diversity of Coxsackievirus A21 associated with sporadic cases of acute respiratory infections in Malaysia
Phase 1b study of intravenous coxsackievirus A21 (V937) and ipilimumab for patients with metastatic uveal melanoma
A.21.
Momente, [...]. A2.1
Liesegang A21